Coronavirus (COVID-19): Advice and guidance for patients, plus the latest visiting restrictions
Dr Hoole qualified in medicine with distinction from University of Oxford, and subsequently trained in cardiology in London and Cambridge. He was appointed as a consultant interventional cardiologist in September 2011 and currently holds a national clinical excellence bronze award.
He has published over 100 peer reviewed manuscripts and is a senior research fellow at the University of Cambridge. He is a specialist adviser to MHRA interventional device program, NICE interventional procedures program and the NIHR HTA program. He is an Expert Adviser for the NICE Centre for Guidelines and has participated in guideline and position paper publications for the ESC, ACC, AHA and NICE and is currently appointed as a NICE clinical guideline chair. He is regularly asked to act as a medicolegal expert and has an efficient and busy private practice.
Dr Hoole is happy to see adult self funding or insured private patients with any cardiological problem but he has a specialist interest in relieving patients of angina and in particular, performing complex coronary intervention and stenting. This includes the treatment of chronic total occlusions, left main, bifurcation and heavily calcified lesions. He is an expert on stent safety and improving stent outcomes by utilising coronary physiology and advanced imaging techniques. He is also the interventional lead for the UK balloon pulmonary angioplasty service.
Coronary Intervention, chronic total occlusion PCI, Structural Intervention, Interventional Research, CT coronary angiography, cardiac support devices and balloon pulmonary angioplasty for CTEPH
Coronary stent safety
Cardioprotection during PCI
Metabolic optimisation during PCI
Myocardial injury during revascularization
Coronary/left ventricular physiological assessment during PCI
Coronary microvascular and collateral function assessment during PCI
Vulnerable plaque imaging with VH-IVUS and OCT
Biomarker profiling during PCI
Coronary intervention risk prediction modeling
Coronary stent design & technology
Innovation of interventional devices
PFO closure in sleep apneoa
Right ventricular haemodynamics
1995 BA (Class: I), University of Oxford
1998 BM BCh, University of Oxford
2001 MRCP, London
2001 MA, University of Oxford
2009 DM, University of Oxford
2010 Board Certified CCT, USA
2016 FRCP, London
Fellow of the Royal College of Physicians, London
Fellow of the American College of Cardiology
Fellow of the European Society of Cardiology
British Cardiovascular Intervention Society
General Medical Council (Full registration: 4530426)
Specialist Advisor to National Institute for Health and Clinical Excellence
Specialist Advisor to NIHR HTA Programme
Specialist Adviser to MHRA Interventional Devices Programme
Member of NICE NCGC Acute Chest Pain Guideline Committee, RCP
Member of Regional Specialist Training Committee (Cardiology), Eastern Deanery
NICE Clinical Guideline Chair
Elected Member of Early Career Section Leadership Council, ACC
To view Dr Hoole's clinical outcomes, please click on this link. This will take you to the British Cardiovascular Intervention Society website which is not part of the Royal Papworth Hospital website.
Selected Journal Publications:
Bamborough P, Hoole SP. Recent Advances in PCI. Heart 2020 in press
Hoole SP, Jenkins DP. CTEPH - interventional approaches Heart 2020 in press
Hoole SP, Coghlan JG, Cannon J, Taboada D, Toshner M, Sheares K, Fletcher A, Martinez G, Ruggiero A, Screaton N, Jenkins D and Pepke-Zaba J. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension in the UK. Open Heart 2020 in press
Al-Hussaini A, Abdelaty AMSEK, Gulsin SK, Arnold J, Garcia-Guimaraes M, Premawardhana D, Budgeon C, Wood A, Natarajan N, Mangion K, Rakhit R, Hoole SP, Johnson TW, Berry C, Hudson I, Gershlick AH, Ladwiniec A, Kovac J,
Squire I, Samani NJ, Plein S, McCann GP, Adlam D. Chronic infarct size after spontaneous coronary artery dissection: implications for pathophysiology and clinical management
European Heart Journal 2020 in press
Garg S, Chichareon P, Kogame N, Takahashi K, Modolo R, Chang CC, Tomaniak M, Fath-Ordoubadi F, Anderson R, Oldroyd KG, Stables RH, Kukreja N, Chowdhary S, Galasko G, Hoole SP, Zaman A, Hamm CW, Steg PG, Jüni P, Valgimigli M, Windecker S, Onuma Y, Serruys PW. Impact of established cardiovascular disease on outcomes in the randomized GLOBAL LEADERS trial. Catheter Cardiovasc Interv. 2019 in press
Chang CC, Spitzer E, Chichareon P, Takahashi K, Modolo R, Kogame N, Tomaniak M, Komiyama H, Yap SC, Hoole SP, Gori T, Zaman A, Frey B, Ferreira RC, Bertrand OF, Koh TH, Sousa A, Moschovitis A, van Geuns RJ, Steg PG, Hamm C, Jüni P, Vranckx P, Valgimigli M, Windecker S, Serruys PW, Soliman O, Onuma Y. Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial). Am J Cardiol. 2019;124(12):1833-1840.
Hausenloy DJ, Kharbanda RK, Møller UK, Ramlall M, Aarøe J, Butler R, Bulluck H, Clayton T, Dana A, Dodd M, Engstrom T, Evans R, Lassen JF, Christensen EF, Garcia-Ruiz JM, Gorog DA, Hjort J, Houghton RF, Ibanez B, Knight R, Lippert FK, Lønborg JT, Maeng M, Milasinovic D, More R, Nicholas JM, Jensen LO, Perkins A, Radovanovic N, Rakhit RD, Ravkilde J, Ryding AD, Schmidt MR, Riddervold IS, Sørensen HT, Stankovic G, Varma M, Webb I, Terkelsen CJ, Greenwood JP, Yellon DM, Bøtker HE. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. CONDI-2/ERIC-PPCI Investigators. Lancet. 2019;394(10207):1415-1424.
Shah N, Meira LB, Elliott RM, Hoole SP, West NE, Brown AJ, Bennett MR, Garcia-Garcia HM, Kuku KO, Dan K, Kolm P, Mariathas M, Curzen N, Mahmoudi M.DNA damage and repair in patients with coronary artery disease: Correlation with plaque morphology using optical coherence tomography (DECODE study). Cardiovasc Revasc Med. 2019;20(9):812-818
Giblett JP, Clarke SJ, Zhao T, McCormick LM, Braganza DM, Densem CG, O’Sullivan M, Adlam D, Clarke SC, Steele J, Fielding S, West NEJ, Villar SS, Hoole SP. The role of GLP-1 Loading on Peri-procedural myocardial infarction During elective PCI (GOLD-PCI study): a randomized, placebo-controlled trial. Am Heart J 2019;215:41-51
Blackman DJ, Saraf S, MacCarthy PA, Myat A, Anderson SG, Malkin CJ, Cunnington MS, Somers K, Brennan P, Manoharan G, Parker J, Aldalati O, Brecker SJ, Dowling C, Hoole SP, Dorman S, Mullen M, Kennon S, Jerrum M, Chandrala P, Roberts DH, Tay J, Doshi S, Ludman PF, Fairbairn TA, Crowe J, Levy RD, AP Banning, Ruparelia N, Spence MS, Hildick-Smith D. Long-Term Durability of Transcatheter Aortic Valve Prostheses. J Am Coll Cardiol 2019;73:537–45
Giblett JP, Axell RG, White PA, Aetesam-Ur-Rahman M, Clarke SJ, O’Sullivan M, Braganza DM, Figg N, Bennett MR, West NEJ, Hoole SP. GLP-1 mediated cardioprotection does not reduce RV stunning and cumulative ischemic dysfunction after coronary balloon occlusion. JACC Basic Translational Science 2019;4(2):222-233
Rahman H, Corcoran D, Aetesam-Ur-Rahman M, Hoole SP, Berry C, Perera D. Diagnosis and stratification of patients with chest pain and non-obstructive coronary disease: a practical, standardised approach in the cardiac catheter laboratory. Heart 2019;105:1536-1542
Liou KP, Ooi S-Y M, Hoole SP, West NEJ. Fractional flow reserve in acute coronary syndrome: A meta-analysis and systematic review. Open Heart 2018 in press
Floré V, Brown AJ, Giblett JP, Liou K, Cranley J, Hoole SP, West NEJ. Clinical outcomes of bioresorbable vascular scaffolds implanted with routine versus selective optical coherence tomography guidance: results from a single-center experience. Eurointervention 2018 in press
Clarke SJ, Giblett JP, Yang L, Hubsch A, O’Sullivan M, Figg N, Bennett MR, Zhao T, Albrechtsen NJW, Deacon CF, Cheriyan J, Hoole SP. GLP-1 is a Coronary Artery Vasodilator in Humans. JAHA 2018 in press
Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Möllmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. GLOBAL LEADERS Investigators. Lancet. 2018 Sep 15;392 (10151):940-949.
Floré V, Brown AJ, Pettit SJ, West NEJ, Lewis C, Parameshwar JK, Hoole SP. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy. Clin Transplant. 2017;e13167. https://doi.org/10.1111/ctr.13167
Hoole SP, Hernández-Sánchez J, Brown AJ, Giblett JP, Bennett MR, West NE. Prediction of post percutaneous coronary intervention myocardial infarction: insights from intravascular imaging, coronary flow and biomarker evaluation. Coron Artery Dis 2017 in press
Hoole SP, Hernández-Sánchez J, Davies WR, McNab DC, Calvert PA, Rana BS, Shapiro LM, Davies MG. Effects of Patent Foramen Ovale closure on Obstructive Sleep Apnoea Syndrome (PCOSA study) Can J Cardiol. 2017;33(12):1708-1715
Escaned J, Collet C, Ryan N, De Maria GL, Walsh S, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, Hoole SP, West NEJ, Piek JJ, Zaman A, Fath-Ordoubadi F, Stables RH, Appleby C, van Mieghem N, van Geuns RJ, Uren N, Zueco J, Buszman P, Iñiguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, Hanratty C, Cavalcante R, Kappetein AP, Taggart DP, van Es G-A, Morel M-A, de Vries T, Onuma Y, Farooq V, Serruys PW, Banning AP. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. European Heart Journal 2017 38(42):3124-3134
Brown AJ, Giblett JP, Bennett MR, West NEJ, Hoole SP. Anatomical plaque and vessel characteristics are associated with hemodynamic indices including fractional flow reserve and coronary flow reserve: a prospective exploratory intravascular ultrasound analysis. Int J Cardiol. 2017 248:92-96
West NEJ, Corrigan JP, Owen RHG, Hoole SP, Brown AJ, Blatcher S, Newby AC. Percutaneous sampling of local biomolecule gradients across coronary artery atherosclerotic plaques. JACC Basic Translational Science 2017 in press
Axel RG, Giblett JP, White PA, Klein A, Hampton-Til J, O’Sullivan M, Braganza DM, Davies WR, West NE, Densem CG, Hoole SP. Stunning and Right Ventricular Dysfunction is Induced by Coronary Balloon Occlusion and Rapid Pacing in Humans: Insights from Right Ventricular Conductance Catheter Studies. JAHA 2017 6(6) pii: e005820. doi: 10.1161/JAHA.117.005820.
Costopoulos C, Huang Y, Brown AJ, Calvert PA, Hoole SP, West NEJ, Gillard JH, Teng Z, Bennett MR. Plaque rupture in coronary atherosclerosis is associated with increased plaque structural stress. JACC Imaging 2017 10(12):1472-1483
Axell RG, Messer SJ, White PA, McCabe C, Priest A, Statopoulou T, Drozdzynska M, Viscasillas J, Hinchy EC, Hampton-Till J, Alibhai HI, Morrell N, Pepke-Zaba J, Large SR, Hoole SP. Ventriculo-Arterial Coupling Detects Occult RV Dysfunction in Chronic Thromboembolic Pulmonary Vascular Disease. Physiological Reports 2017 5(7). pii: e13227. doi: 10.14814/phy2.13227.
Axell RG, White PA, Giblett JP, Williams L, Rana BS, Klein A, O’Sullivan M, Davies WR, Densem CG, Hoole SP. Rapid Pacing Induced Right Ventricular Dysfunction is Evident after Balloon Expandable Trans-femoral Aortic Valve Replacement. J Am Coll Card 2017 69(7): 903-904
Ladwiniec A, White PA, Nijjer SS, O’Sullivan M, West NEJ, Davies JE, Hoole SP. The diastolic backwards-travelling decompression (suction) wave correlates with simultaneously acquired indices of diastolic function and is reduced in left ventricular stunning Circ Intervention 2016 9(9) pii: e003779. doi: 10.1161/CIRCINTERVENTIONS.116.003779.
Giblett JP, Axell RG, White PA, Clarke SJ, McCormick L, Read PA, Reinhold J, Brown AJ, O’Sullivan M, West NEJ, Dutka DP, Hoole SP. Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies. Cardiovasc Diabetol. 2016 15:99
Adlam D (Chair), Alfonso F, Maas A, Vrints C, al Hussaini A (UK), Bueno H (Spain), Capranzano P (Italy), Gevaert S (Belgium), Hoole SP (UK), Johnson T (UK), Lettieri C (Italy), Maeder MT (Switzerland), Montreff P (France), Ong P (Germany), Persu A (Belgium), Rikli H (Switzerland), Schiele F (France), Sheppard M (UK), Swahn E (Sweden). European Society of Cardiology - Acute Cardiovascular Care Association, SCAD Study Group - A position paper on Spontaneous Coronary Artery Dissection. European Heart Journal 2018 doi:10.1093/eurheartj/ehy080
Giblett JG, Hoole SP. Remote Ischemic Conditioning in Elective PCI? Journal of Cardiovascular Pharmacology & Therapeutics 2017 22(4):310-315.
Giblett JP, Clarke SJ, Dutka DP, Hoole SP. Glucagon-like Peptide-1: a promising agent for cardioprotection during myocardial ischemia. JACC Basic Translational Science 2016 1 (4), 267-276
Hoole SP, Clarke SC. Navigating optimal revascularisation for unprotected left main disease in changing interventional seas. JACC Cardiovasc Interv 2016 9(10):1008-10
Brown AJ, Teng Z, Calvert PA, Rajani NK, Hennessy O, Obaid DR, Costopoulos C, Huang Y, Hoole SP, Goddard M, West NEJ, Gillard JH, Bennett MR Plaque structural stress estimations improve prediction of future major adverse cardiovascular events following intracoronary imaging. Circ Cardiovasc Imaging 2016 in press
Giblett JP, SJ Clarke, DP Dutka, Hoole SP Glucagon-like Peptide-1: a promising agent for cardioprotection during myocardial ischemia. JACC Basic Translational Science 2016 in press
Giblett JP, Brown AJ, Keevil H, Jaworski C, Hoole SP, West NEJ Implantation of Bioresorbable Vascular Scaffolds following Acute Coronary Syndrome is Associated with Reduced Neointimal Growth and Strut Coverage. Eurointervention 2016 in press
Hoole SP, Clarke SC Navigating optimal revascularisation for unprotected left main disease in changing interventional seas. JACC Cardiovasc Interv 2016 9(10):1008-10
Hoole SP, West NEJ What is the place of bivalirudin in contemporary invasive treatment of acute coronary syndromes? BMJ 2016 352:i86
Brown AJ, Calvert PA, Hoole SP, Obaid DR, West NEJ, Bennett MR Geographical miss is associated with vulnerable plaque and increased major adverse cardiovascular events in patients with myocardial infarction. CCI 2015 doi: 10.1002/ccd.26275.
Brown AJ, Costopoulos C, Obaid D, Parker R, Calvert PA, Teng Z, Hoole SP, Goddard M, West NEJ, Bennett MR. Direct comparison of virtual-histology intravascular ultrasound and optical coherence tomography imaging for identification of thin-cap fibroatheroma. Circ Cardiovasc Imaging 2015 ;8:e003487. DOI: 10.1161/CIRCIMAGING.115.003487
Costopoulos C, Brown AJ, Hoole SP, West NE Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold implantation in a real-world population: a single-center experience. Cardiovasc Revasc Medicine 2015, 16(8):461-4.
McCormick LM, Heck PM, Ring LS, Kydd AC, Clarke SJ, Hoole SP, Dutka DP Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus. Cardiovasc Diabet 2015 14:102 doi:10.1186/s12933-015-0259-3
Costopoulos C, Brown AJ, Teng Z, Hoole SP, West NE, Samady H, Bennett MR Intravascular ultrasound and optical coherence tomography imaging of coronary atherosclerosis. Int J Cardiovasc Imaging 2015, 32(1):189-200
Abah U, Dunne M, Cook A, Hoole SP, Brayne C, Vale L, Large S Does Quality of Life improve in Octogenarians following Cardiac Surgery? A Systematic Review. BMJ Open 2015 5(4):e006904. doi: 10.1136/bmjopen-2014-006904
Brown AJ, Hoole SP, West NEJ Optical Coherence Tomography Imaging of Coronary Atherosclerosis is Affected by Intra and Inter-observer Variability. J Cardiovasc Med 2015 17(5):368-73
Hoole SP, Brown AJ, Jaworski C, McCormick LM, Clarke SC, West NEJ Interpretation of Fractional Flow Reserve in ST-Elevation Myocardial Infarction Culprit Lesions. Coron Artery Dis 2015 26(6): 495-502
Ranjani NK, Brown AJ, Hoole SP, West NEJ Switching from Transfemoral to Transradial Access for Percutaneous Coronary Intervention – Do The Benefits Perceived in RCTs Translate to Routine Practice. J Interv Card 2015 28 (3), 296-304, 2015
Hoole SP, Jaworski C, Brown AJ, McCormick LM, Agrawal B, Clarke SC, West NEJ Serial Assessment of the Index of Microcirculatory Resistance during Primary Percutaneous Coronary Intervention comparing Manual Aspiration Catheter Thrombectomy with Balloon Angioplasty (IMPACT study) - a Randomised Controlled Pilot Study. OpenHeart 2015 2 (1), e000238, 2015
Giblett JP, West NEJ, Hoole SP. Cardioprotection for Percutaneous Coronary Intervention – Reperfusion Quality as well as Quantity. Int J Cardiol. 2014, 177(3): 786-793
McCormick LM, Hoole SP, White PA, Read PA, Axell RG, Clarke SJ, O’Sullivan M, West NEJ, Dutka DP Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization. JACC Cardiovasc Interv 2015: 8(2): 292-301
McCormick LM, Brown AJ, Ring LS, Gajendragadkar PR, Dockrill SJ, Hansom SP, Giblett JP, Gilbert TJ, Hoole SP, West NE Direct stenting is an independent predictor of improved survival in patients undergoing primary PCI for STEMI. EHJ ACC 2014 3(4):340-6
Brown AJ, McCormick LM, Braganza DM, Bennett MR, Hoole SP, West NEJ Expansion and malapposition characteristics after OCT guided bioresorbable vascular scaffold implantation Catheter Cardiovasc Interv 2014, 84(1):37-45
McCabe C, White PA, Rana BS, Gopalan D , Agrawal B, Pepke-Zaba J, Hoole SP RV functional assessment: have new techniques supplanted the old faithful conductance catheter? Cardio in Review 2014, 22(5):233-40.
McCormick LM, Kydd AC, Read PR, Ring LS, Hoole SP, Dutka DP Chronic DPP-4 Inhibition with Sitigliptin Is Associated with Sustained Protection Against Ischemic LV Dysfunction in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease Circ Imaging 2014 7(2):274-81
Teng Z, Brown AJ, Calvert PA, Parker RA, Obaid DR, Huang Y, Hoole SP, West NEJ, Gillard JH, Bennett MR Coronary plaque structural stress is determined by plaque composition and subtype and increased in acute coronary syndrome: the BEACON I (Biomechanical Evaluation of Atheromatous COroNary Arteries) Study Circ Imaging 2014 7(3):461-70
McCabe C, White PA, Hoole SP, Axell R, Priest A, Gopalan D, Taboada D, MacKenzie-Ross R, Morrell N, Shapiro LM, Pepke-Zaba J Right Ventricular Dysfunction in Chronic Thromboembolic Obstruction of the Pulmonary Artery. J Appl Physiol 2014, 116(4):355-63
Brown AJ, McCormick LM, Gajendragadkar PR, Hoole SP, West NEJ. Initial SYNTAX score predicts major adverse cardiac events after primary percutaneous coronary intervention. Angiology 2014, 65(5):408-12.
Obaid DR, Calvert PA, Gopalan D, Hoole SP, West NEJ, Goddard M, Rudd JHF, Bennett MR. Atherosclerotic plaque composition and classification identified by coronary CT: Assessment of CT- generated plaque maps compared with VH-IVUS and histology Circ Cardiovasc Imaging 2013 6(5):655-64
Davies WR, Brown AJ, Watson W, McCormick LM, West NEJ, Dutka DP, Hoole SP. Remote Ischemic Pre-conditioning Improves Outcome at Six Years Following Elective Percutaneous Coronary Intervention: The CRISP-Stent Trial Long Term Follow-Up. Circ Intervention 2013, 6(3):246-51
Brown AJ, Hoole SP, McCormick LM, Malone-Lee M, Cacciottolo PJ, Schofield PM, West NEJ. Left bundle branch block with acute thrombotic occlusion is associated with increased myocardial jeopardy score and poor clinical outcomes in primary percutaneous coronary intervention activations. Heart 2013, 99(11):774-8.
Rekhraj S, McNab DC, Shapiro LM, Hoole SP, Rana BS Hypoxia in a patient with carcinoid syndrome J Am Coll Cardiol 2013, 62(17): e241
Brown AJ, McCormick LM, Hoole SP, West NEJ. Co-registered intravascular ultrasound and optical J Am Coll Cardiol 2013coherence tomography imaging during implantation of a bioresorbable vascular scaffold. JACC Cardiovasc Interv 2013, 6(7): e41-42
Hoole SP, Rana B, Shapiro LM, Davies M. No closure for patent foramen ovale in obstructive sleep apnea? Chest 2013;143(2):581-2
Vassiliou V, West NEJ, Hoole SP. Kounis syndrome: not to be sneezed at. Heart 2013;99(1):68.
McCormick LM, Hoole SP, Brown AJ, Dutka DP, West NE. A contemporary re-evaluation of culprit lesion severity in patients presenting with STEMI. Acute Card Care. 2012;14(4):111-6.
Hoole SP, White PA, Read PA, Heck PM, West NE, O’Sullivan M, Dutka DP. Coronary Collaterals Provide a Constant Scaffold Effect on the Left Ventricle and Limit Ischemic Left Ventricular Dysfunction in Humans. J Appl Physiol. 2012;112(8):1403-9.
Hoole SP, Seddon MD, Poulter RS, Mancini GBJ, Wood DA, Saw J.Development and Validation of the FFR Angiographic Scoring Tool (FAST) to Improve the Angiographic Grading and Selection of Intermediate Lesions that Require FFR Assessment. Coron Artery Dis 2012, 23(1): 45-50
Read PA, Hoole SP, White PA, Khan FZ, O’Sullivan M, West NEJ, Dutka DP. A Pilot Study to Assess Whether Glucagon-like peptide-1 protects the Heart from Ischemic Dysfunction and Attenuates Stunning Following Coronary Balloon Occlusion in Humans. Circ Intervention 2011, 4(3): 266-72
Hoole SP, Seddon MD, Poulter RS, Mancini GBJ, Wood DA, Saw J. FAME comes at a cost – a Canadian Analysis of Procedural Costs in Using Pressure Wire to Guide Multivessel PCI. Can J Cardiol. 2011, 27 (2): 262
Hoole SP, Hamburger JN. Comparing Procedural Risks to Select the Optimal Revascularization Strategy –Certainty in an Uncertain Anatomical World. Catheter Cardiovasc Interv 2011, 77 (2): 313-314
Hoole SP, Heck PM, Epstein AC, Clarke SC, West NE, Dutka DP. Elective Coronary Stenting Increases Fractional Flow Reserve in other arteries due to an increase in Microvascular Resistance: Clinical Implications for Assessment of Multi-vessel disease. J Interv Card 2010, 23(6):520-7.
Hoole SP, Heck PM, Sharples L, Dutka DP West NEJ. Coronary stent length predicts PCI-induced cardiac myonecrosis. Coron Artery Dis 2010, 21(5): 312-7
Heck PM, Hoole SP, Khan SN, Dutka DP. Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.
Cardiovasc Diabetol 2010, 9:27
Hoole SP, Heck PM, White PA, Read PA, Khan SN, West NEJ, O’Sullivan M, Dutka DP. Stunning and Cumulative LV Dysfunction Occurs Late after Coronary Balloon Occlusion in Humans: Insights from Simultaneous Coronary and LV Hemodynamic Assessment. JACC Cardiovasc Interv 2010, 3(4): 412-8
West NEJ, Hoole SP, McCormick LAre All Distal Protection Devices Created Equal? J Am Coll Cardiol 2010, 56(9):745-6
Read PA, Khan FZ, Heck PM, Hoole SP, Dutka DP.DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease. Circ Cardiovasc Imaging 2010, 3(2): 195-201
Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O’Sullivan M, Dutka DP. Cardiac Remote ISchemic Preconditioning in Coronary Stenting (CRISP stent) Study: a prospective, randomized controlled trial. Circulation 2009, 119: 820-827
Hoole SP, Khan SN, White PA, Heck PM, Kharbanda RK, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O’Sullivan M, Dutka DP. Remote Ischaemic Preconditioning Does Not Attenuate Ischaemic Left Ventricular Dysfunction in Humans. Eur J Heart Failure 2009, 11: 497-505
Hoole SP, White PA, Heck PM, Khan SN, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O’Sullivan M, Dutka DP. Primary Coronary Microvascular Dysfunction and Poor Coronary Collaterals Predict Post-PCI Cardiac Necrosis.
Coron Artery Dis 2009, 20 (4):253-259
Hoole SP, Heck PM, White PA, Khan SN, O’Sullivan M, Clarke SC, Dutka DP. Angiology 2009, 60 (4):403-11. Remote Ischemic Preconditioning Stimulus Does Not Reduce Microvascular Resistance or Improve Myocardial Blood Flow in Patients Undergoing Elective Percutaneous Coronary Intervention.
Cases for PACES 4e. Hoole SP, Fry A, Davies RJ. Wiley Blackwell Publishing Group 2020 in press
Coronary Angiography, Core Topics in Cardiothoracic Critical Care. Krishnan U, Hoole SP. Editors: Valchanov K, Jones N, Hogue C. Cambridge University Press 2016 in press
Cases for PACES 3e. Hoole SP, Fry A, Davies RJ. ISBN-10 1-1189-8357-2 Wiley Blackwell Publishing Group, 2015
Cases for PACES 2e. Hoole SP, Hodson DJ, Fry A, Davies RJ. ISBN 1-4051-9948-2 Wiley Blackwell Publishing Group, 2010
Cases for PACES. Hoole SP, Hodson DJ and Fry A. ISBN 1-4051-1093-7 Blackwell Publishing Ltd, 2003
SwitchBoard: 01223 638000
Tel: 01223 639758